Assignee
ZHU ZHENGLUN
US·8 granted patents·13 pending applications·5 citations·filing 2007–2024
Top patents by PatentIndex Score
21 records- 0182US11248252B2Treatment and diagnosis of immune disordersZHU ZHENGLUN·Filed 2018·Granted Feb 15, 2022·1 cites·9 claims
- 0282US2025019763A1Homeobox transcription factor ventx regulates differentiation and maturation of human dendritic cellsZHU ZHENGLUN·Filed 2024·Application pending·0 cites
- 0382US2025188474A1Treatment and diagnosis of inflammatory disordersZHU ZHENGLUN·Filed 2024·Application pending·0 cites
- 0482US2025235512A1Method of modifying macrophage differentiation and immunityZHU ZHENGLUN·Filed 2024·Application pending·0 cites
- 0580US11268095B2Treatment and diagnosis of inflammatory disordersZHU ZHENGLUN·Filed 2017·Granted Mar 8, 2022·1 cites·4 claims
- 0680US2025281616A1Methods for treating neoplastic diseasesZHU ZHENGLUN·Filed 2024·Application pending·0 cites
- 0777US2024374638A1Methods for treating neoplastic diseasesZHU ZHENGLUN·Filed 2024·Application pending·0 cites
- 0876US12146138B2Treatment and diagnosis of inflammatory disordersZHU ZHENGLUN·Filed 2022·Granted Nov 19, 2024·0 cites·7 claims
- 0976US7994126B2Treatment of cellular proliferative disorders with compositions comprising Hom polypeptide (also known as Xom, VENTX2)ZHU ZHENGLUN·Filed 2007·Granted Aug 9, 2011·2 cites·11 claims
- 1074US2024132935A1Treatment and diagnosis of immune disordersZHU ZHENGLUN·Filed 2022·Application pending·0 cites
- 1170US8741865B2Treatment of immune disorders with Hom-1 inhibitorsZHU ZHENGLUN·Filed 2010·Granted Jun 3, 2014·1 cites·9 claims
- 1269US2021393682A1Method of modifying macrophage differentiation and immunityZHU ZHENGLUN·Filed 2021·Application pending·0 cites
- 1369US2020224272A1Homeobox transcription factor ventx regulates differentiation and maturation of human dendritic cellsZHU ZHENGLUN·Filed 2019·Application pending·0 cites
- 1467US2020023006A1Methods for treating neoplastic diseasesZHU ZHENGLUN·Filed 2019·Application pending·0 cites
- 1560US10544460B2Homeobox transcription factor ventx regulates differentiation and maturation of human dendritic cellsZHU ZHENGLUN·Filed 2014·Granted Jan 28, 2020·0 cites·2 claims
- 1659US2025283050A1Method of cancer treatmentZHU ZHENGLUN·Filed 2022·Application pending·0 cites
- 1759US2014315205A1Treatment and diagnosis of immune disordersZHU ZHENGLUN·Filed 2014·Application pending·0 cites
- 1858US8993227B2Cancer prognosis by determining phosphorylation of a Xom polypeptideZHU ZHENGLUN·Filed 2013·Granted Mar 31, 2015·0 cites·15 claims
- 1958US2018325949A1Method of modifying macrophage differentiation and immunityZHU ZHENGLUN·Filed 2016·Application pending·0 cites
- 2049US2011300549A1Treatment of Development-Related DisordersZHU ZHENGLUN·Filed 2011·Application pending·0 cites
- 2141US10066272B2Human homeobox gene ventx and macrophage terminal differentiation and activation, compositions and methods thereofZHU ZHENGLUN·Filed 2012·Granted Sep 4, 2018·0 cites·5 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →